Blog

Reckoning the potential of CRISPR/Cas9 tech, NIH launches $190M genome editing research initiative – Endpoints News


Endpoints News

Reckoning the potential of CRISPR/Cas9 tech, NIH launches $190M genome editing research initiative
Endpoints News
As the first human trial involving CRISPR comes into view in the United States, the NIH has stepped up with a $190 million research initiative to help float all the boats riding on the wave of new genome editing technologies. Named Somatic Cell Genome

and more »

2018-01-24 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.